Mesenchymal cell transfer for articular cartilage repair

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Mature articular cartilage has a poor reparative response to injury and its irreparable breakdown is the common feature of degenerative joint diseases. If articular cartilage lesions become symptomatic, the orthopaedic surgeon must decide on a treatment option. The treatment options include conversion of chondral lesions to osteochondral lesions, which facilitates migration of cells from the marrow space to effect repair. In recent years, a greater emphasis has been placed on tissue engineering strategies and thus several new treatment options have been introduced, including the use of cell transplantation. Several tissue sources and cell types can potentially be used for this type of therapy. These include autologous or allograft chondrocytes and mesenchymal progenitor cells from various tissues. These cells may be delivered to articular cartilage lesions by a variety of methods including direct cell injection to the lesion or seeding in a biodegradable scaffold prior to implantation. In this review, the potential of cell transplantation for articular cartilage repair and regeneration will be discussed. The authors will focus on the available technologies and the present limitations of cell-based therapies.

Original languageEnglish (US)
Pages (from-to)915-921
Number of pages7
JournalExpert Opinion on Biological Therapy
Volume1
Issue number6
DOIs
StatePublished - Nov 1 2001

Fingerprint

Cartilage
Articular Cartilage
Repair
Cell Transplantation
Tissue
Orthopedics
Therapeutics
Tissue Engineering
Chondrocytes
Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
Tissue engineering
Scaffolds
Osteoarthritis
Cell Movement
Allografts
Regeneration
Bone Marrow
Cells
Technology

Keywords

  • articular cartilage
  • chondrocyte
  • mesenchymal progenitor cell repair
  • stem cell

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry
  • Drug Discovery
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Mesenchymal cell transfer for articular cartilage repair. / Johnstone, Brian; Yoo, Jung.

In: Expert Opinion on Biological Therapy, Vol. 1, No. 6, 01.11.2001, p. 915-921.

Research output: Contribution to journalArticle

@article{587b7237a9584254878d4ecaea23f69d,
title = "Mesenchymal cell transfer for articular cartilage repair",
abstract = "Mature articular cartilage has a poor reparative response to injury and its irreparable breakdown is the common feature of degenerative joint diseases. If articular cartilage lesions become symptomatic, the orthopaedic surgeon must decide on a treatment option. The treatment options include conversion of chondral lesions to osteochondral lesions, which facilitates migration of cells from the marrow space to effect repair. In recent years, a greater emphasis has been placed on tissue engineering strategies and thus several new treatment options have been introduced, including the use of cell transplantation. Several tissue sources and cell types can potentially be used for this type of therapy. These include autologous or allograft chondrocytes and mesenchymal progenitor cells from various tissues. These cells may be delivered to articular cartilage lesions by a variety of methods including direct cell injection to the lesion or seeding in a biodegradable scaffold prior to implantation. In this review, the potential of cell transplantation for articular cartilage repair and regeneration will be discussed. The authors will focus on the available technologies and the present limitations of cell-based therapies.",
keywords = "articular cartilage, chondrocyte, mesenchymal progenitor cell repair, stem cell",
author = "Brian Johnstone and Jung Yoo",
year = "2001",
month = "11",
day = "1",
doi = "10.1517/14712598.1.6.915",
language = "English (US)",
volume = "1",
pages = "915--921",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Mesenchymal cell transfer for articular cartilage repair

AU - Johnstone, Brian

AU - Yoo, Jung

PY - 2001/11/1

Y1 - 2001/11/1

N2 - Mature articular cartilage has a poor reparative response to injury and its irreparable breakdown is the common feature of degenerative joint diseases. If articular cartilage lesions become symptomatic, the orthopaedic surgeon must decide on a treatment option. The treatment options include conversion of chondral lesions to osteochondral lesions, which facilitates migration of cells from the marrow space to effect repair. In recent years, a greater emphasis has been placed on tissue engineering strategies and thus several new treatment options have been introduced, including the use of cell transplantation. Several tissue sources and cell types can potentially be used for this type of therapy. These include autologous or allograft chondrocytes and mesenchymal progenitor cells from various tissues. These cells may be delivered to articular cartilage lesions by a variety of methods including direct cell injection to the lesion or seeding in a biodegradable scaffold prior to implantation. In this review, the potential of cell transplantation for articular cartilage repair and regeneration will be discussed. The authors will focus on the available technologies and the present limitations of cell-based therapies.

AB - Mature articular cartilage has a poor reparative response to injury and its irreparable breakdown is the common feature of degenerative joint diseases. If articular cartilage lesions become symptomatic, the orthopaedic surgeon must decide on a treatment option. The treatment options include conversion of chondral lesions to osteochondral lesions, which facilitates migration of cells from the marrow space to effect repair. In recent years, a greater emphasis has been placed on tissue engineering strategies and thus several new treatment options have been introduced, including the use of cell transplantation. Several tissue sources and cell types can potentially be used for this type of therapy. These include autologous or allograft chondrocytes and mesenchymal progenitor cells from various tissues. These cells may be delivered to articular cartilage lesions by a variety of methods including direct cell injection to the lesion or seeding in a biodegradable scaffold prior to implantation. In this review, the potential of cell transplantation for articular cartilage repair and regeneration will be discussed. The authors will focus on the available technologies and the present limitations of cell-based therapies.

KW - articular cartilage

KW - chondrocyte

KW - mesenchymal progenitor cell repair

KW - stem cell

UR - http://www.scopus.com/inward/record.url?scp=0035515606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035515606&partnerID=8YFLogxK

U2 - 10.1517/14712598.1.6.915

DO - 10.1517/14712598.1.6.915

M3 - Article

C2 - 11728225

AN - SCOPUS:0035515606

VL - 1

SP - 915

EP - 921

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 6

ER -